Ironwood Pharmaceuticals, Inc.  

(Public, NASDAQ:IRWD)   Watch this stock  
Find more results for IRWD
12.94
0.00 (0.00%)
Real-time:   12:44PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.88 - 13.05
52 week 8.95 - 15.95
Open 13.00
Vol / Avg. 512,887.00/1.19M
Mkt cap 1.79B
P/E     -
Div/yield     -
EPS -1.76
Shares 120.64M
Beta 1.58
Inst. own 108%
Oct 20, 2014
Q3 2014 Ironwood Pharmaceuticals Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Aug 4, 2014
Q2 2014 Ironwood Pharmaceuticals Inc Earnings Call - Webcast
Aug 4, 2014
Q2 2014 Ironwood Pharmaceuticals Inc Earnings Release
Jun 11, 2014
Ironwood Pharmaceuticals Inc at Goldman Sachs Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -882.41% -1192.31%
Operating margin -805.83% -1101.36%
EBITD margin - -1050.10%
Return on average assets -61.29% -107.22%
Return on average equity -146.38% -299.34%
Employees 534 -
CDP Score - -

Address

301 BINNEY STREET
CAMBRIDGE, MA 02142-1030
United States - Map
+1-617-6217722 (Phone)
+1-617-4940480 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Ironwood Pharmaceuticals, Inc. is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines. The Company is engaged in the area of guanylate cyclase type-C (GC-C), agonists and in the science and treatment of gastrointestinal diseases. Its two GC-C agonists are linaclotide and IW-9179.

Officers and directors

Bryan E. Roberts Ph.D. Independent Chairman of the Board
Age: 47
Bio & Compensation  - Reuters
Peter M. Hecht Ph.D. Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Michael J. Higgins Chief Financial Officer, Chief Operating Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Mark G. Currie Ph.D. Senior Vice President, Chief Scientific Officer, President - Research and Development
Age: 59
Bio & Compensation  - Reuters
Thomas A. McCourt Senior Vice President - Marketing and Sales, Chief Commercial Officer
Age: 56
Bio & Compensation  - Reuters
Gina Consylman Chief Accounting Officer, Vice President, Corporate Controller
Age: 42
Bio & Compensation  - Reuters
Douglas E. Williams Ph.D. Director
Age: 56
Bio & Compensation  - Reuters
George H. Conrades Independent Director
Age: 75
Bio & Compensation  - Reuters
Joseph C. Cook Jr. Independent Director
Age: 72
Bio & Compensation  - Reuters
David A. Ebersman Independent Director
Age: 44
Bio & Compensation  - Reuters